We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
Cap. Flow
+$2.78B
Cap. Flow %
12.74%
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699

Sector Composition

Rank Sector Weight
1 Healthcare 20.03%
2 Consumer Discretionary 13.15%
3 Technology 10.68%
4 Financials 9.81%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTB
1526
DELISTED
Cooper Tire & Rubber Co.
CTB
$1.28M 0.01%
+22,834
New +$1.09M
ERIE icon
1527
Erie Indemnity
ERIE
$12.7B
$1.28M 0.01%
+5,778
New +$1.4M
ELYS
1528
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$1.28M 0.01%
+240,792
New +$1.39M
KEP icon
1529
Korea Electric Power
KEP
$14.9B
$1.27M 0.01%
124,146
+88,139
+245% +$952K
OPK icon
1530
Opko Health
OPK
$1.25B
$1.27M 0.01%
296,137
+15,301
+5% +$73.1K
PRLD icon
1531
Prelude Therapeutics
PRLD
$370M
$1.27M 0.01%
+29,315
New +$1.94M
PCT icon
1532
PureCycle Technologies
PCT
$1.24B
$1.27M 0.01%
+49,730
New +$1.46M
XPDIU
1533
DELISTED
Power & Digital Infrastructure Acquisition Corp. Unit
XPDIU
$1.26M 0.01%
+125,000
New +$1.33M
JNK icon
1534
PUT
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.06B
$1.26M 0.01%
+11,600
New +$1.26M
USPH icon
1535
US Physical Therapy
USPH
$1.2B
$1.26M 0.01%
+12,103
New +$1.51M
VECO icon
1536
Veeco
VECO
$2.79B
$1.26M 0.01%
60,718
+43,031
+243% +$894K
ASML icon
1537
ASML
ASML
$608B
$1.26M 0.01%
2,039
+1,315
+182% +$729K
AEP icon
1538
American Electric Power
AEP
$72.4B
$1.26M 0.01%
14,825
-1,100
-7% -$88.7K
RRGB icon
1539
Red Robin
RRGB
$139M
$1.25M 0.01%
31,341
+4,228
+16% +$128K
PII icon
1540
Polaris
PII
$4.07B
$1.24M 0.01%
9,320
-46,147
-83% -$5.62M
SES icon
1541
SES AI
SES
$196M
$1.24M 0.01%
+124,986
New +$1.26M
INSE icon
1542
Inspired Entertainment
INSE
$188M
$1.23M 0.01%
+132,852
New +$1.04M
ELMSW
1543
CALL
DELISTED
Electric Last Mile Solutions, Inc. Warrant
ELMSW
$1.23M 0.01%
123,712
+40,383
+48% +$113K
VELOU
1544
DELISTED
Velocity Acquisition Corp. Units
VELOU
$1.23M 0.01%
+125,000
New +$1.25M
CKH
1545
DELISTED
Seacor Holdings Inc.
CKH
$1.23M 0.01%
+30,265
New +$1.27M
NTNX icon
1546
Nutanix
NTNX
$16B
$1.23M 0.01%
+46,352
New +$1.41M
SHOE
1547
Shoe Station Group
SHOE
$431M
$1.23M 0.01%
+39,752
New +$980K
WPC icon
1548
W.P. Carey
WPC
$16.8B
$1.23M 0.01%
+17,746
New +$1.19M
VERI icon
1549
Veritone
VERI
$96.7M
$1.23M 0.01%
51,098
+27,357
+115% +$976K
GAIA icon
1550
Gaia
GAIA
$47.6M
$1.23M 0.01%
103,004
+59,459
+137% +$647K

Similar funds

Marshall Wace's Q1 2021 Portfolio in Review

As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.

  • Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
  • Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
  • Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
  • Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
  • Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
  • Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.